<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412022001100893</article-id>
<article-id pub-id-type="doi">10.24245/gom.v90i11.8072</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Eficacia y seguridad del misoprostol vaginal comparado con dinoprostona en maduración cervical e inducción del parto]]></article-title>
<article-title xml:lang="en"><![CDATA[Effectiveness and safety of vaginal misoprostol vs dinoprostone for cervical ripening and labour induction.]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Beira-Salvador]]></surname>
<given-names><![CDATA[Pedro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aneiros-Campos]]></surname>
<given-names><![CDATA[Yaiza]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González-Seoane]]></surname>
<given-names><![CDATA[Raquel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Veiga-Tuimil]]></surname>
<given-names><![CDATA[Manuel Ángel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Área Sanitaria de Ferrol  ]]></institution>
<addr-line><![CDATA[Ferrol La Coruña]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<volume>90</volume>
<numero>11</numero>
<fpage>893</fpage>
<lpage>900</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412022001100893&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412022001100893&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412022001100893&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  OBJETIVO: Comparar la eficacia del misoprostol intravaginal con el dispositivo vaginal de liberación prolongada de dinoprostona en la inducción del parto. Además, analizar el perfil de seguridad en relación con los desenlaces maternos y perinatales.  MATERIALES Y MÉTODOS: Estudio retrospectivo y comparativo efectuado en pacientes atendidas entre 2018 y 2020 en el Área Sanitaria de Ferrol, La Coruña, España, con partos que se iniciaron con inducción con prostaglandinas. Las pacientes se dividieron en dos cohortes, en función de la prostaglandina sintética administrada (misoprostol por vía vaginal o dinoprostona en dispositivo intravaginal). Para la comparación entre ambos grupos se aplicó la prueba U de Mann-Whitney. Para las variables cualitativas se describió su cantidad total y el porcentaje, que se compararon con prueba de &#967;2 de Pearson.  RESULTADOS: Se analizaron 508 pacientes con inducción del parto. En las indicaciones de ésta no se encontraron diferencias entre uno y otro grupo, aunque destacó la indicación del misoprostol en pacientes con embarazo cronológicamente prolongado (63%) y de dinoprostona en rotura prematura de membranas (49%). En relación con los desenlaces perinatales, se registró un Apgar menor de 7 a los 5 minutos en 2 pacientes tratadas con dinoprostona y 1 con misoprostol; así como un pH arterial umbilical menor de 7.10 en 8 pacientes tratadas con dinoprostona y 7 con misoprostol.  CONCLUSIONES: Los datos aquí reportados hacen suponer que ambas prostaglandinas consiguen una tasa de inicio del parto similar, aunque la dinoprostona parece reducir el tiempo hasta el inicio del parto en mujeres con indicación de inducción.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  OBJECTIVE: To compare the efficacy of intravaginal misoprostol with the dinoprostone extended-release vaginal device in labor induction. In addition, to analyze the safety profile in relation to maternal and perinatal outcomes.  MATERIALS AND METHODS: Retrospective and comparative study performed in patients attended between 2018 and 2020 in the Health Area of Ferrol, La Coruña, Spain, with deliveries that were initiated with prostaglandin induction. The patients were divided into two cohorts, depending on the synthetic prostaglandin administered (misoprostol vaginally or dinoprostone in intravaginal device). The Mann-Whitney U test was used to compare the two groups. For qualitative variables, the total number and percentage were described and compared with Pearson&amp;apos;s 2 test.  RESULTS: A total of 508 patients undergoing labor induction were analyzed. No differences were found in the indications for induction of labor between one group and the other, although the indication for misoprostol in patients with chronologically prolonged pregnancy (63%) and for dinoprostone in premature rupture of membranes (49%) stood out. In relation to perinatal outcomes, an Apgar of less than 7 at 5 minutes was recorded in 2 patients treated with dinoprostone and 1 with misoprostol; as well as an umbilical arterial pH of less than 7.10 in 8 patients treated with dinoprostone and 7 with misoprostol.  CONCLUSIONS: The data reported here suggest that both prostaglandins achieve a similar rate of onset of labor, although dinoprostone appears to reduce the time to onset of labor in women indicated for induction.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Embarazo]]></kwd>
<kwd lng="es"><![CDATA[inducción del parto]]></kwd>
<kwd lng="es"><![CDATA[embarazo prolongado]]></kwd>
<kwd lng="es"><![CDATA[misoprostol]]></kwd>
<kwd lng="es"><![CDATA[dinoprostona]]></kwd>
<kwd lng="es"><![CDATA[España]]></kwd>
<kwd lng="en"><![CDATA[Pregnancy]]></kwd>
<kwd lng="en"><![CDATA[Labor induction]]></kwd>
<kwd lng="en"><![CDATA[Pregnancy, prolonged]]></kwd>
<kwd lng="en"><![CDATA[Misoprostol]]></kwd>
<kwd lng="en"><![CDATA[Dinoprostone]]></kwd>
<kwd lng="en"><![CDATA[Spain]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>EURO&#8208;PERISTAT Project with SCPE and EUROCA</collab>
<source><![CDATA[The health and care of pregnant women and babies in Europe in 2010]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laughon]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Grewal]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sundaram]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Beaver]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Reddy]]></surname>
<given-names><![CDATA[UM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Induction of labor in a contemporary obstetric cohort]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>2012</year>
<volume>206</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>486.e1-9</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<collab>ACOG</collab>
<article-title xml:lang=""><![CDATA[Practice Bulletin No. 107: Induction of Labor]]></article-title>
<source><![CDATA[Obstetrics &amp; Gynecology]]></source>
<year>2009</year>
<volume>114</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>386-97</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Zheng]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Fu]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hou]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy and safety of misoprostol compared with the dinoprostone for labor induction at term: a meta-analysis]]></article-title>
<source><![CDATA[J Maternal-Fetal &amp; Neonatal Medicine]]></source>
<year>2016</year>
<volume>29</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1297-307</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hertelendy]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Zakár]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prostaglandins and the myometrium and cervix]]></article-title>
<source><![CDATA[Prostaglandins Leukot Essent Fatty Acids]]></source>
<year>2004</year>
<volume>70</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>207-22</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rath]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Osmers]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Adelmann-Grill]]></surname>
<given-names><![CDATA[BC]]></given-names>
</name>
<name>
<surname><![CDATA[Stuhlsatz]]></surname>
<given-names><![CDATA[HW]]></given-names>
</name>
<name>
<surname><![CDATA[Szvereny]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kuhn]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biochemical changes in human cervical connective tissue after intracervical application of prostaglandin E2]]></article-title>
<source><![CDATA[Prostaglandins]]></source>
<year>1993</year>
<volume>45</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>375-84</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boulvain]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Irion]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intracervical prostaglandins for induction of labour]]></article-title>
<source><![CDATA[Cochrane Database of Systematic Reviews]]></source>
<year>2008</year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<collab>SEGO</collab>
<source><![CDATA[Protocolo de inducción del parto]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Allen]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[O&#8217;Brien]]></surname>
<given-names><![CDATA[BM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uses of misoprostol in obstetrics and gynecology]]></article-title>
<source><![CDATA[Rev Obstet Gynecol]]></source>
<year>2009</year>
<volume>2</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Church]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[van Meter]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Whitfield]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical Round: Dinoprostone compared with Misoprostol for cervical ripening for induction of labor at term]]></article-title>
<source><![CDATA[J Midwifery Women&#8217;s Health]]></source>
<year>2009</year>
<volume>54</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>405-11</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wing]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Sheibani]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacotherapy options for labor induction]]></article-title>
<source><![CDATA[Expert Opin Pharmacother]]></source>
<year>2015</year>
<volume>16</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1657-68</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gerriets]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<source><![CDATA[Prostaglandin E2 (Dinoprostone)]]></source>
<year>2022</year>
<publisher-loc><![CDATA[Treasure Island (FL) ]]></publisher-loc>
<publisher-name><![CDATA[Stat Publishing]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Austin]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Sanchez-Ramos]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Adair]]></surname>
<given-names><![CDATA[CD.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Labor induction with intravaginal misoprostol compared with the dinoprostone vaginal insert: a systematic review and metaanalysis]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>2010</year>
<volume>202</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>624.e1-9</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wing]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz-Omphroy]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Paul]]></surname>
<given-names><![CDATA[RH.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>1997</year>
<volume>177</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>612-8</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rozenberg]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Chevret]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sénat]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
<name>
<surname><![CDATA[Bretelle]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Paule Bonnal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ville]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A randomized trial that compared intravaginal misoprostol and dinoprostone vaginal insert in pregnancies at high risk of fetal distress]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>2004</year>
<volume>191</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>247-53</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rozenberg]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Chevret]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Goffinet]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Induction of labour with a viable infant: a randomised clinical trial comparing intravaginal misoprostol and intravaginal dinoprostone]]></article-title>
<source><![CDATA[BJOG]]></source>
<year>2001</year>
<volume>108</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1255-62</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buser]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Mor]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Arias]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A randomized comparison between misoprostol and dinoprostone for cervical ripening and labor induction in patients with unfavorable cervices]]></article-title>
<source><![CDATA[Obstetrics &amp; Gynecology]]></source>
<year>1997</year>
<volume>89</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>581-5</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alfirevic]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Keeney]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Dowswell]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Labour induction with prostaglandins: a systematic review and network meta-analysis]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2015</year>
<volume>350</volume>
<page-range>h217</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cheng]]></surname>
<given-names><![CDATA[SY]]></given-names>
</name>
<name>
<surname><![CDATA[Ming]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[JC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Titrated oral compared with vaginal misoprostol for labor induction]]></article-title>
<source><![CDATA[Obstetrics &amp; Gynecology]]></source>
<year>2008</year>
<volume>111</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>119-25</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rouzi]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Alsibiani]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mansouri]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Alsinani]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Darhouse]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Randomized clinical trial between hourly titrated oral misoprostol and vaginal dinoprostone for induction of labor]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>2014</year>
<volume>210</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>56.e1-6</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caughey]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
<name>
<surname><![CDATA[Cahill]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Guise]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Rouse]]></surname>
<given-names><![CDATA[DJ.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safe prevention of the primary cesarean delivery]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>2014</year>
<volume>210</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>179-93</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maggi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mazzoni]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gerosa]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Labor induction with misoprostol vaginal insert compared with dinoprostone vaginal insert]]></article-title>
<source><![CDATA[Acta Obstet Gynecol Scand]]></source>
<year>2019</year>
<volume>98</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1268-73</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[ankin]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Chodankar]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Raymond]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Bhaskar]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Misoprostol vaginal insert versus dinoprostone vaginal insert: A comparison of labour and delivery outcomes]]></article-title>
<source><![CDATA[Eur J Obstet Gynecol Reproductive Biology]]></source>
<year>2019</year>
<volume>235</volume>
<page-range>93-6</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wing]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Plante]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Rugarn]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Powers]]></surname>
<given-names><![CDATA[BL.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Misoprostol vaginal insert and time to vaginal delivery]]></article-title>
<source><![CDATA[Obstetrics &amp; Gynecology]]></source>
<year>2013</year>
<volume>122</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>201-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
